TRIPLE A INVESTMENTS
Triple A Investments facilitates high-level international funding for Government and Public-Private Partnership (PPP) projects in Africa, Asia, Europe and the Middle East.
In healthcare, our group represents a Molecular Diagnostic for Genetic Diseases and Oncology, providing early detection for breast and cervical cancer.
Triple A Investments represents a Molecular Diagnostics Centre for Genetic Diseases and Oncology (Cancer), providing early detection for breast and cervical cancer. Molecular Diagnostics facilitates correct treatment, saving valuable time in treatment compared with conventional clinical diagnosis.
Early detection of cancers increases the success of treatment and life expectancy is extended for patients.